Seattle, WA, United States of America

Michael Kovarik

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michael Kovarik: Innovator in Enzyme Technology

Introduction

Michael Kovarik is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of enzyme technology. With a total of five patents to his name, he has made remarkable advancements in the directed evolution of enzymes, particularly in the area of DNA polymerases.

Latest Patents

Kovarik's latest patents include groundbreaking work on the directed evolution of enzymes by plasmid tagging in droplets. This method focuses on the selection of nucleic acid processing enzymes, specifically DNA polymerases, with desired properties. Another notable patent involves recombinant DPO4-type DNA polymerase variants, which feature amino acid substitutions that enhance the polymerase's properties for improved single molecule sequencing applications. These innovations allow for better binding and incorporation of bulky nucleotide analog substrates into daughter strands.

Career Highlights

Throughout his career, Michael Kovarik has worked with leading companies in the biotechnology sector, including Stratos Genomics, Inc. and Roche Sequencing Solutions, Inc. His work has significantly impacted the development of advanced sequencing technologies and enzyme applications.

Collaborations

Kovarik has collaborated with notable professionals in his field, including Mark Stamatios Kokoris and Marc Prindle. These partnerships have further enriched his research and development efforts.

Conclusion

Michael Kovarik's innovative work in enzyme technology and his contributions to the field of DNA polymerases highlight his role as a leading inventor. His patents and collaborations continue to influence advancements in biotechnology and sequencing applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…